Rochester (1)

Acute Myeloid Leukemia With FLT3/ITD Mutation (1)

Acute Myeloid Leukemia With Gene Mutations (1)

FLT3 Tyrosine Kinase Domain Point Mutation (1)

Secondary Acute Myeloid Leukemia (1)

Untreated Adult Acute Myeloid Leukemia (1)

Terminated (1)

phase 2 (1)

Mayo Clinic (1)

National Cancer Institute (NCI) (1)

decitabine (1)

laboratory biomarker analysis (1)

midostaurin (1)

drug (1)

other (1)

Other (1)

Interventional (1)

flt3 tyrosine kinase domain point mutation

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

Jul 17, 2019